Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report
In the treatment of clinical cases of drug-induced cholestatic liver disease and hyperlipidemia, it is essential for medical professionals to consider the patient's overall condition, formulate an individualized treatment plan, and closely monitor the patient's biochemical indices and clinical symptoms to ensure treatment efficacy and prognosis.
Authors
- Mengjiao Xu (ORCID: https://orcid.org/0000-0001-6904-9150)
- Xin Wei
- Yao Lu
- Lei Sun
- Ming-Hui Li
- Yao Xie
Institutions
- Capital Medical University (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.4254/wjh.v17.i12.111414
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00